Atrial fibrillatory rate in the clinical context: Natural course and prediction of intervention outcome

Europace

Volumn 16, Issue , 2014, Pages iv110-iv119

  Platonov, Pyotr G ^a   Corino, Valentina D A ^b   Seifert, Mariam ^a   Holmqvist, Fredrik ^a   Sörnmo, Leif ^a  

^a LUND UNIVERSITY   (Sweden)

^b POLITECNICO DI MILANO   (Italy)

Author keywords

Atrial; Atrial fibrillation

Indexed keywords

ANTIARRHYTHMIC AGENT;

ATRIAL FIBRILLATION; ATRIAL FIBRILLATORY RATE; AUTONOMIC NERVOUS SYSTEM; CARDIOVASCULAR PARAMETERS; CARDIOVERSION; CATHETER ABLATION; DISEASE COURSE; DRUG EFFECT; DRUG MONITORING; ELECTROCARDIOGRAM; HEART ELECTROPHYSIOLOGY; HUMAN; INTERVENTION STUDY; POWER SPECTRUM; PRIORITY JOURNAL; REFERENCE VALUE; REVIEW; ACTION POTENTIAL; ANIMAL; BIOLOGICAL MODEL; ELECTROCARDIOGRAPHY; HEART ATRIUM; HEART ATRIUM REMODELING; HEART MUSCLE CONDUCTION SYSTEM; HEART RATE; PATHOPHYSIOLOGY; PREDICTIVE VALUE; REFRACTORY PERIOD; TIME; TREATMENT OUTCOME;

ACTION POTENTIALS; ANIMALS; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; ATRIAL REMODELING; CATHETER ABLATION; ELECTRIC COUNTERSHOCK; ELECTROCARDIOGRAPHY; HEART ATRIA; HEART CONDUCTION SYSTEM; HEART RATE; HUMANS; MODELS, CARDIOVASCULAR; PREDICTIVE VALUE OF TESTS; REFRACTORY PERIOD, ELECTROPHYSIOLOGICAL; TIME FACTORS; TREATMENT OUTCOME;

EID: 84923531287     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/euu249     Document Type: Review

References (69)

1. Wijffels MC, Kirchhof CJ, Dorland R, Allessie MA. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation 1995;92: 1954-68.
2. Asano Y, Saito J, Matsumoto K, Kaneko K, Yamamoto T, Uchida M. On the mechanism of termination and perpetuation of atrial fibrillation. Am J Cardiol 1992;69: 1033-8.
3. Haissaguerre M, Lim KT, Jacquemet V, Rotter M, Dang L, Hocini Met al. Atrial fibrillatory cycle length: computer simulation and potential clinical importance. Europace 2007;9(Suppl 6):vi64-70.
4. Lewis T. Auricular fibrillation: a common clinical condition. BMJ 1909;42:1528.
5. Bollmann A, Kanuru NK, McTeague KK,Walter PF, DeLurgio DB, Langberg JJ. Frequency analysis of human atrial fibrillation using the surface electrocardiogram and its response to ibutilide. Am J Cardiol 1998;81:1439-45.
6. Holm M, Pehrson S, Ingemansson M, Sornmo L, Johansson R, Sandhall L et al. Noninvasive assessment of the atrial cycle length during atrial fibrillation in man: introducing, validating and illustrating a new ECG method. Cardiovasc Res 1998;38:69-81.
7. Matsuo S, Lellouche N, Wright M, Bevilacqua M, Knecht S, Nault I et al. Clinical predictors of termination and clinical outcome of catheter ablation for persistent atrial fibrillation. J Am Coll Cardiol 2009;54:788-95.
8. Husser D, Cannom DS, Bhandari AK, Stridh M, Sornmo L, Olsson SB et al. Electrocardiographic characteristics of fibrillatory waves in new-onset atrial fibrillation. Europace 2007;9:638-42.
9. Holmqvist F, Stridh M,Waktare JE, Roijer A, Sornmo L, Platonov PG et al. Atrial fibrillation signal organization predicts sinus rhythm maintenance in patients undergoing cardioversion of atrial fibrillation. Europace 2006;8:559-65.
10. Petersson R, Sandberg F, Platonov PG, Holmqvist F. Noninvasive estimation of organization in atrial fibrillation as a predictor of sinus rhythm maintenance. J Electrocardiol 2011;44:171-5.
11. Alcaraz R, Sandberg F, Sornmo L, Rieta JJ. Classification of paroxysmal and persistent atrial fibrillation in ambulatory ECG recordings. IEEE Trans Biomed Eng 2011;58: 1441-9.
12. Petrutiu S, Sahakian AV, Fisher W, Swiryn S. Manifestation of left atrial events and interatrial frequency gradients in the surface electrocardiogram during atrial fibrillation: contributions from posterior leads. J Cardiovasc Electrophysiol 2009;20: 1231-6.
13. Husser D, Stridh M, Sornmo L, Toepffer I, Klein HU, Bertil Olsson S et al. Electroatriography - time-frequency analysis of atrial fibrillation from modified 12-lead ECG configurations for improved diagnosis and therapy. Med Hypotheses 2007;68: 568-73.
14. Ihara Z, van Oosterom A, Jacquemet V, Hoekema R. Adaptation of the standard 12-lead electrocardiogram system dedicated to the analysis of atrial fibrillation. J Electrocardiol 2007;40:68 e1-8.
15. Sörnmo L, Stridh M, Rieta JJ. Atrial activity extraction from the ECG. In Mainardi LT, Sörnmo L, Cerutti S (eds). Understanding Atrial Fibrillation: The Signal Processing Contribution. San Francisco, USA: Morgan & Claypool Publishers; 2008. p53-80.
16. Bollmann A, Husser D, Mainardi L, Lombardi F, Langley P, Murray A et al. Analysis of surface electrocardiograms in atrial fibrillation: techniques, research, and clinical applications. Europace 2006;8:911-26.
17. Lemay M, Vesin JM, van Oosterom A, Jacquemet V, Kappenberger L. Cancellation of ventricular activity in the ECG: evaluation of novel and existing methods. IEEE Trans Biomed Eng 2007;54:542-6.
18. Alcaraz R, Rieta JJ. Adaptive singular value cancelation of ventricular activity in singlelead atrial fibrillation electrocardiograms. Physiol Meas 2008;29:1351-69.
19. Llinares R, Igual J. Application of constrained independent component analysis algorithms in electrocardiogram arrhythmias. Artif Intell Med 2009;47:121-33.
20. Lee J, Song MH, Shin DG, Lee KJ. Event synchronous adaptive filter based atrial activity estimation in single-lead atrial fibrillation electrocardiograms. Med Biol Eng Comput 2012;50:801-11.
21. Petrenas A, Marozas V, Sornmo L, Lukosevicius A. An echo state neural network for QRST cancellation during atrial fibrillation. IEEE Trans Biomed Eng 2012;59:2950-7.
22. Sandberg F, Sörnmo L, Stridh M. Time-frequency analysis of atrial fibrillation. In Mainardi LT, Sörnmo L, Cerutti S (eds). Understanding Atrial Fibrillation: The Signal Processing Contribution. San Francisco, USA: Morgan & Claypool Publishers; 2008. p81-102.
23. Corino VD, Sandberg F, Lombardi F, Mainardi LT, Sörnmo L. Atrioventricular nodal function during atrial fibrillation: model building and robust estimation. Biomed Signal Process Control 2013;8:1017-25.
24. Corino VD, Mainardi LT, Stridh M, Sornmo L. Improved time-frequency analysis of atrial fibrillation signals using spectral modeling. IEEE Trans Biomed Eng 2008;55: 2723-30.
25. Sandberg F, Stridh M, Sornmo L. Frequency tracking of atrial fibrillation using hidden Markov models. IEEE Trans Biomed Eng 2008;55:502-11.
26. Sassi R, Corino VD, Mainardi LT. Analysis of surface atrial signals: time series with missing data? Ann Biomed Eng 2009;37:2082-92.
27. Meurling CJ, Ingemansson MP, Roijer A, Carlson J, Lindholm CJ, Smideberg B et al. Attenuation of electrical remodelling in chronic atrial fibrillation following oral treatment with verapamil. Europace 1999;1:234-41.
28. Xi Q, Sahakian AV, Ng J, Swiryn S. Atrial fibrillatory wave characteristics on surface electrogram: ECG to ECG repeatability over twenty-four hours in clinically stable patients. J Cardiovasc Electrophysiol 2004;15:911-7.
29. Holmqvist F, Stridh M,Waktare JE, Sornmo L, Olsson SB, Meurling CJ. Atrial fibrillatory rate and sinus rhythm maintenance in patients undergoing cardioversion of persistent atrial fibrillation. Eur Heart J 2006;27:2201-7.
30. Bollmann A, Sonne K, Esperer HD, Toepffer I, Langberg JJ, Klein HU. Non-invasive assessment of fibrillatory activity in patients with paroxysmal and persistent atrial fibrillation using the Holter ECG. Cardiovasc Res 1999;44:60-6.
31. Petrutiu S, Sahakian AV, Swiryn S. Short-term dynamics in fibrillatory wave characteristics at the onset of paroxysmal atrial fibrillation in humans. J Electrocardiol 2007;40:155-60.
32. Ravelli F, Mase M, Del Greco M, Faes L, Disertori M. Deterioration of organization in the first minutes of atrial fibrillation: a beat-to-beat analysis of cycle length and wave similarity. J Cardiovasc Electrophysiol 2007;18:60-5.
33. Platonov PG, Stridh M, de Melis M, Urban L, Carlson J, Corbucci G et al. Analysis of atrial fibrillatory rate during spontaneous episodes of atrial fibrillation in humans using implantable loop recorder electrocardiogram. J Electrocardiol 2012;45:723-6.
34. Petrutiu S, Sahakian AV, Swiryn S. Abrupt changes in fibrillatory wave characteristics at the termination of paroxysmal atrial fibrillation in humans. Europace 2007;9: 466-70.
35. Fujiki A, Sakabe M, Nishida K, Mizumaki K, Inoue H. Role of fibrillation cycle length in spontaneous and drug-induced termination of human atrial fibrillation. Circ J 2003; 67:391-5.
36. Bollmann A, Sonne K, Esperer HD, Toepffer I, Klein HU. Circadian variations in atrial fibrillatory frequency in persistent human atrial fibrillation. Pacing Clin Electrophysiol 2000;23:1867-71.
37. Meurling CJ,Waktare JE, Holmqvist F, Hedman A, CammAJ, Olsson SB et al. Diurnal variations of the dominant cycle length of chronic atrial fibrillation. Am J Physiol Heart Circ Physiol 2001;280:H401-6.
38. Sandberg F, Bollmann A, Husser D, Stridh M, Sornmo L. Circadian variation in dominant atrial fibrillation frequency in persistent atrial fibrillation. Physiol Meas 2010;31: 531-42.
39. Bollmann A,Wodarz K, Esperer HD, Toepffer I, Klein HU. Response of atrial fibrillatory activity to carotid sinus massage in patients with atrial fibrillation. Pacing Clin Electrophysiol 2001;24:1363-8.
40. Holmqvist F, Stridh M,Waktare JE, Brandt J, Sornmo L, Roijer A et al. Rapid fluctuations in atrial fibrillatory electrophysiology detected during controlled respiration. Am J Physiol Heart Circ Physiol 2005;289:H754-60.
41. Stridh M, Meurling C, Olsson B, Sornmo L. Detection of autonomic modulation in permanent atrial fibrillation. Med Biol Eng Comput 2003;41:625-9.
42. Ingemansson MP, Holm M, Olsson SB. Autonomic modulation of the atrial cycle length by the head up tilt test: non-invasive evaluation in patients with chronic atrial fibrillation. Heart 1998;80:71-6.
43. Östensson SE, Platonov PG. Modulation of atrial fibrillatory rate during head-up and head-down tilt test in patients with persistent atrial fibrillation. Heart Rhythm Society's 35th Annual Scientific Sessions. 2014. [Abstract].
44. Husser O, Husser D, Stridh M, Sornmo L, Corino VD, Mainardi LT et al. Exercise testing for non-invasive assessment of atrial electrophysiological properties in patients with persistent atrial fibrillation. Europace 2007;9:627-32.
45. Sanders P, Nalliah CJ, Dubois R, Takahashi Y, Hocini M, Rotter M et al. Frequency mapping of the pulmonary veins in paroxysmal versus permanent atrial fibrillation. J Cardiovasc Electrophysiol 2006;17:965-72.
46. Bollmann A, Tveit A, Husser D, Stridh M, Sornmo L, Smith P et al. Fibrillatory rate response to candesartan in persistent atrial fibrillation. Europace 2008;10:1138-44.
47. Choudhary MB, Holmqvist F, Carlson J, Nilsson HJ, Roijer A, Platonov PG. Low atrial fibrillatory rate is associated with spontaneous conversion of recent-onset atrial fibrillation. Europace 2013;15:1445-52.
48. Platonov PG, Cygankiewicz I, Stridh M, Holmqvist F, Vazquez R, Bayes-Genis A et al. Low atrial fibrillatory rate is associated with poor outcome in patients with mild to moderate heart failure. Circ Arrhythm Electrophysiol 2012;5:77-83.
49. Swartz MF, FinkGW, Lutz CJ, Taffet SM, Berenfeld O, Vikstrom KL et al. Left versus right atrial difference in dominant frequency, K(+) channel transcripts, and fibrosis in patients developing atrial fibrillation after cardiac surgery. Heart Rhythm 2009;6: 1415-22.
50. Husser D, Stridh M, Sornmo L, Roden DM, Darbar D, Bollmann A. A genotypedependent intermediate ECG phenotype in patients with persistent lone atrial fibrillation genotype ECG-phenotype correlation in atrial fibrillation. Circulation Arrhythm Electrophysiol 2009;2:24-8.
51. Seifert MB, Olesen MS, Christophersen IE, Nielsen JB, Carlson J, TveitAet al. The lack of association between genomic predictors of atrioventricular conduction and atrial electrocal remodeling in patients with lone atrial fibrillation. Heart Rhythm Society's 35th Annual Scientific Sessions. 2014. [Abstract].
52. Wijffels MC, Dorland R, Mast F, Allessie MA. Widening of the excitable gap during pharmacological cardioversion of atrial fibrillation in the goat: effects of cibenzoline, hydroquinidine, flecainide, and d-sotalol. Circulation 2000;102:260-7.
53. Husser D, Stridh M, Sornmo L, Geller C, Klein HU, Olsson SB et al. Time-frequency analysis of the surface electrocardiogram for monitoring antiarrhythmic drug effects in atrial fibrillation. Am J Cardiol 2005;95:526-8.
54. Aunes-Jansson M, Edvardsson N, Stridh M, Sornmo L, Frison L, Berggren A. Decrease of the atrial fibrillatory rate, increased organization of the atrial rhythm and termination of atrial fibrillation by AZD7009. J Electrocardiol 2013;46:29-35.
55. Aunes M, Egstrup K, Frison L, Berggren A, Stridh M, Sornmo L et al. Rapid slowing of the atrial fibrillatory rate after administration of AZD7009 predicts conversion of atrial fibrillation. J Electrocardiol 2013.
56. John S, Salmas J, Kornej J, Lobe S, Stridh M, Sornmo L et al. Effects of dronedarone and amiodarone on atrial fibrillatory rate in patients with persistent atrial fibrillation. Int J Cardiol 2013;167:2354-6.
57. Corino VD, Holmqvist F, Mainardi LT, Platonov PG. Beta-blockade and A1-adenosine receptor agonist effects on atrial fibrillatory rate and atrioventricular conduction in patients with atrial fibrillation. Europace 2014;16:587-94.
58. Raine D, Langley P, Murray A, Dunuwille A, Bourke JP. Surface atrial frequency analysis in patients with atrial fibrillation: a tool for evaluating the effects of intervention. J Cardiovasc Electrophysiol 2004;15:1021-6.
59. Bollmann A, Mende M, Neugebauer A, Pfeiffer D. Atrial fibrillatory frequency predicts atrial defibrillation threshold and early arrhythmia recurrence in patients undergoing internal cardioversion of persistent atrial fibrillation. Pacing Clin Electrophysiol, 2002;25:1179-84.
60. Bollmann A, Husser D, Steinert R, Stridh M, Soernmo L, Olsson SB et al. Echocardiographic and electrocardiographic predictors for atrial fibrillation recurrence following cardioversion. J Cardiovasc Electrophysiol 2003;14:S162-5.
61. Meurling CJ, Roijer A,Waktare JE, Holmqvist F, Lindholm CJ, Ingemansson MP et al. Prediction of sinus rhythm maintenance following DC-cardioversion of persistent atrial fibrillation - the role of atrial cycle length. BMC Cardiovasc Disord 2006;6:11.
62. Efremidis M, Alexanian IP, Oikonomou D, Manolatos D, Letsas KP, Pappas LK et al. Predictors of atrial fibrillation recurrence in patients with long-lasting atrial fibrillation. Can J Cardiol 2009;25:e119-24.
63. Bollmann A, Binias KH, Toepffer I, Molling J, Geller C, Klein HU. Importance of left atrial diameter and atrial fibrillatory frequency for conversion of persistent atrial fibrillation with oral flecainide. Am J Cardiol 2002;90:1011-4.
64. Schwartz RA, Langberg JJ. Atrial electrophysiological effects of ibutilide infusion in humans. Pacing Clin Electrophysiol 2000;23:832-6.
65. Fujiki A, Tsuneda T, Sugao M, Mizumaki K, Inoue H. Usefulness and safety of bepridil in converting persistent atrial fibrillation to sinus rhythm. Am J Cardiol 2003;92: 472-5.
66. Fujiki A, Sakabe M, Nishida K, Sugao M, Tsuneda T, Iwamoto J et al. Drug-induced changes in fibrillation cycle length and organization index can predict chemical cardioversion of long-lasting atrial fibrillation with bepridil alone or in combination with aprindine. Circ J 2004;68:1139-45.
67. Mochalina N, Juhlin T, Öhlin B, Carlson J, Holmqvist F, Platonov PG. Predictors of successful cardioversion with vernakalant in patients with recent-onset atrial fibrillation. Ann Noninvasive Electrocardiol 2014. Jul 9. doi: 10.1111/anec.12178. [Epub ahead of print].
68. Fedida D, Orth PM, Chen JY, Lin S, Plouvier B, Jung G et al. The mechanism of atrial antiarrhythmic action of RSD1235. J Cardiovasc Electrophysiol 2005;16:1227-38.
69. Platonov PG, Mitrofanova LB, Orshanskaya V, Ho SY. Structural abnormalities in atrial walls are associated with presence and persistency of atrial fibrillation but not with age. J Am Coll Cardiol 2011;58:2225-32.